By Michael Macagnone ( March 24, 2015, 3:29 PM EDT) -- A pharmaceutical industry group on Tuesday told a D.C. Circuit panel to toss a Federal Trade Commission rule requiring disclosure of more exclusive patent licenses for approval under federal merger law, saying the law does not allow the agency to target a particular industry....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.